Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 9/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29198889 | 0.86 | CYP1A2 (0.48) | CYP1A2ALDH1A1ALOX15TDP1USP2 | |
| SCHEMBL13646108 | 0.80 | USP2 (0.41) | CYP1A2ALDH1A1ALOX15TDP1USP2 | |
| SCHEMBL15926259 | 0.79 | CYP1A2 (0.48) | CYP1A2ALDH1A1ALOX15TDP1USP2 | |
| SCHEMBL28116925 | 0.78 | CYP1A2 (0.41) | CYP1A2ALDH1A1ALOX15TDP1USP2 | |
| SCHEMBL24393166 | 0.78 | ALDH1A1 (0.43) | CYP1A2ALDH1A1ALOX15TDP1USP2 | |
| SCHEMBL25884523 | 0.77 | ALDH1A1 (0.43) | CYP1A2ALDH1A1ALOX15TDP1USP2 | |
| Hydrochloric Acid SCHEMBL23215573 | 0.76 | ALDH1A1 (0.42) | CYP1A2ALDH1A1ALOX15TDP1USP2 | |
| SCHEMBL852008 | 0.76 | CYP1A2 (0.46) | CYP1A2ALDH1A1ALOX15TDP1USP2 | |
| SCHEMBL28783772 | 0.76 | CYP1A2 (0.42) | CYP1A2ALDH1A1ALOX15TDP1USP2 | |
| Hydrochloric Acid SCHEMBL29602469 | 0.75 | GNAO1 (0.46) | CYP1A2ALDH1A1ALOX15TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230202977-A1 | CYCLIC LIPIDS AND METHODS OF USE THEREOF | RENAGADE THERAPEUTICS MANAGEMENT INC. | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202977-A1 | CYCLIC LIPIDS AND METHODS OF USE THEREOF | SGMS1, SGMS2, LNPEP | CYP1A2 4878/4885ALDH1A1 4882/4885ALOX15 1197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.